NVCR - NovoCure's (NVCR) CEO Asaf Danziger on Q4 2018 Results - Earnings Call Transcript
NovoCure (NVCR)
Q4 2018 Earnings Conference Call
February 28, 2019 8:00 AM ET
Company Participants
Ashley Cordova — Senior Vice President-Finance and Investor Relations
Bill Doyle — Executive Chairman
Wilco Groenhuysen — Chief Financial Officer
Eilon Kirson — Chief Science Officer and Head of Research & Development
Asaf Danziger — Chief Executive Officer
Conference Call Participants
Vijay Kumar - Evercore ISI
Difei Yang - Mizuho Securities
Cory Kasimov - JPMorgan
Larry Biegelsen - Wells Fargo
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the NovoCure 2018 Earnings Conference Call. At this time all